在肉瘤中ERK5信号传递的病原性作用:预后和治疗影响
Adrián Sánchez-Fdez1,2,3,4, Sofía Matilla-Almazán1,2,3, Sofía Del Carmen1,5
1Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
Experimental & molecular medicine
|June 18, 2023
概括
在肉瘤发育过程中,MEK5/ERK5通路至关重要. 抑制这种途径会阻止肉瘤细胞的生长和瘤的形成,为这种罕见的癌症提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 瘤是一种罕见的,具有挑战性的癌症,影响所有年龄段,对它们的分子起源的理解有限.
- 鉴定瘤发生的关键分子通路对于发现新的治疗策略至关重要.
研究的目的:
- 研究MEK5/ERK5信号通路在肉瘤发病过程中的作用.
- 探索MEK5/ERK5通路作为潜在的治疗瘤治疗标.
主要方法:
- 开发了一种具有构成性活性MEK5的小鼠模型,以研究瘤发生.
- 进行了瘤的组织病理学和生物信息学分析.
- 评估ERK5表达对患者存活时间的影响.
- 利用药理和遗传方法在人类肉瘤细胞和小鼠模型中准MEK5/ERK5通路.
主要成果:
- 单独激活MEK5/ERK5通路促进了小鼠的肉瘤发育,导致未分化的多形肉瘤.
- 在肉瘤中,ERK5经常被放大和过度表达.
- 增加ERK5表达与患者中位生存时间的5倍下降相关.
- 准MEK5/ERK5通路显著抑制了人类肉瘤细胞的增殖和瘤的生长.
- 在小鼠中,ERK5或MEK5淘汰赛可以防止瘤形成.
结论:
- MEK5/ERK5通路在肉瘤的发病过程中起着至关重要的作用.
- MEK5/ERK5通路代表了对瘤的有前途的治疗标,特别是那些具有这种通路的病理生理参与的人.
相关概念视频
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


